JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.54B |
| 2 |
NVIDIA
NVDA
|
+$5.22B |
| 3 |
Apple
AAPL
|
+$3.2B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.51B |
| 5 |
Walt Disney
DIS
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.6B |
| 2 |
UnitedHealth
UNH
|
+$2.41B |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.15B |
| 4 |
Linde
LIN
|
+$1.93B |
| 5 |
Union Pacific
UNP
|
+$1.87B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.6% |
| 2 | Financials | 9.92% |
| 3 | Consumer Discretionary | 9.63% |
| 4 | Communication Services | 7.24% |
| 5 | Healthcare | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
Red Cat Holdings
RCAT
$1.66B
| $258K | ﹤0.01% |
35,383
+35,272
| +31,777% | +$230K |
|
|
TVACU
4902
Texas Ventures Acquisition III Corp Unit
TVACU
| $257K | ﹤0.01% |
+25,000
| New | +$252K |
|
|
KMTS
4903
Kestra Medical Technologies
KMTS
$1.63B
| $256K | ﹤0.01% |
+15,469
| New | +$338K |
|
4904
Distribution Solutions Group
DSGR
$1.61B
| $255K | ﹤0.01% |
9,301
+31
| +0.3% | +$831 |
|
|
BCAX
4905
Bicara Therapeutics
BCAX
$1.58B
| $255K | ﹤0.01% |
27,458
+5,664
| +26% | +$67.5K |
|
|
PELIU
4906
DELISTED
Pelican Acquisition Corp Unit
PELIU
| $255K | ﹤0.01% |
+25,000
| New | +$252K |
|
4907
Invesco New York AMT-Free Municipal Bond ETF
PZT
$139M
| $254K | ﹤0.01% |
11,752
+3,492
| +42% | +$75.6K |
|
4908
Invesco Mortgage Capital
IVR
$805M
| $254K | ﹤0.01% |
32,431
+1,234
| +4% | +$9.09K |
|
|
ODP
4909
DELISTED
ODP
ODP
| $253K | ﹤0.01% |
13,963
-13,025
| -48% | -$204K |
|
|
EU
4910
enCore Energy
EU
$235M
| $253K | ﹤0.01% |
88,311
-876
| -1% | -$1.57K |
|
|
AXINU
4911
Axiom Intelligence Acquisition Corp 1 Units
AXINU
$193M
| $253K | ﹤0.01% |
+25,000
| New | +$252K |
|
4912
CALL
Garrett Motion
GTX
$5.43B
| $252K | ﹤0.01% |
+24,000
| New | +$242K |
|
4913
Neuberger Option Strategy ETF
NBOS
$528M
| $252K | ﹤0.01% |
9,667
-1,323,415
| -99% | -$33.4M |
|
4914
Preformed Line Products
PLPC
$2.23B
| $252K | ﹤0.01% |
1,574
-1,507
| -49% | -$215K |
|
4915
Zegna
ZGN
$3.72B
| $250K | ﹤0.01% |
29,298
+29,249
| +59,692% | +$236K |
|
4916
CALL
Celestica
CLS
$42.7B
| $250K | ﹤0.01% |
1,600
-12,000
| -88% | -$1.28M |
|
|
TRML
4917
DELISTED
Tourmaline Bio
TRML
| $249K | ﹤0.01% |
15,599
-24,101
| -61% | -$390K |
|
|
JANM
4918
FT U.S. Equity Max Buffer ETF - January
JANM
$36.8M
| $249K | ﹤0.01% |
7,858
+349
| +5% | +$10.8K |
|
4919
Graham Corp
GHM
$1.3B
| $249K | ﹤0.01% |
5,028
-11,606
| -70% | -$430K |
|
|
TSSI
4920
TSS Inc
TSSI
$271M
| $249K | ﹤0.01% |
+8,626
| New | +$113K |
|
4921
Mercer International
MERC
$31.4M
| $249K | ﹤0.01% |
71,033
-130,582
| -65% | -$540K |
|
4922
Sanara MedTech
SMTI
$314M
| $248K | ﹤0.01% |
8,742
-2,978
| -25% | -$89.3K |
|
4923
Zevra Therapeutics
ZVRA
$660M
| $248K | ﹤0.01% |
28,161
-977
| -3% | -$7.93K |
|
4924
USCB Financial Holdings
USCB
$419M
| $248K | ﹤0.01% |
14,991
-11,312
| -43% | -$190K |
|
4925
Weyco Group
WEYS
$433M
| $248K | ﹤0.01% |
7,467
-4,990
| -40% | -$153K |
|
Similar funds
JP Morgan Chase's Q2 2025 Portfolio in Review
As of Q2 2025, JP Morgan Chase held 7,888 positions worth $1.53T, up 12% from $1.37T the previous quarter. Its ten largest holdings account for 25% of the portfolio.
JP Morgan Chase's Q2 2025 filing shows 634 new, 2,516 increased, 3,216 reduced and 855 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.6B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- JP Morgan Chase's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 10,818,420 shares worth $543M.
- JP Morgan Chase added most to Microsoft in Q2 2025, an estimated $6.54B increase.
- JP Morgan Chase's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.6B.
- JP Morgan Chase fully exited Discover Financial Services in Q2 2025, selling an estimated $370M.
- JP Morgan Chase's ten largest holdings make up 25% of its $1.53T portfolio in Q2 2025.
- JP Morgan Chase opened 634 new positions and closed 855 in Q2 2025.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $1.53T.
Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.